93 related articles for article (PubMed ID: 24229619)
1. Oral squamous cell carcinoma and serum paraoxonase 1.
Metin ZB; Aydin S; Unur M; Cakmakoglu B; Toptas B; Hafiz G; İsbir T
J Laryngol Otol; 2013 Dec; 127(12):1208-13. PubMed ID: 24229619
[TBL] [Abstract][Full Text] [Related]
2. Measurement of serum paraoxonase activity and MDA concentrations in patients suffering with oral squamous cell carcinoma.
Malik UU; Siddiqui IA; Hashim Z; Zarina S
Clin Chim Acta; 2014 Mar; 430():38-42. PubMed ID: 24389054
[TBL] [Abstract][Full Text] [Related]
3. Paraoxonase-1 192/55 polymorphisms and the risk of lung cancer in a Turkish population.
Aksoy-Sagirli P; Cakmakoglu B; Isbir T; Kaytan-Saglam E; Kizir A; Topuz E; Berkkan H
Anticancer Res; 2011 Jun; 31(6):2225-9. PubMed ID: 21737645
[TBL] [Abstract][Full Text] [Related]
4. Paraoxonase 1 (PON1) 55 polymorphism, lipid profiles and psoriasis.
Asefi M; Vaisi-Raygani A; Bahrehmand F; Kiani A; Rahimi Z; Nomani H; Ebrahimi A; Tavilani H; Pourmotabbed T
Br J Dermatol; 2012 Dec; 167(6):1279-86. PubMed ID: 22835076
[TBL] [Abstract][Full Text] [Related]
5. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus.
Agachan B; Yilmaz H; Karaali Z; Isbir T
Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181
[TBL] [Abstract][Full Text] [Related]
6. Association of polymorphisms in Tumor Necrosis Factor Alpha and Beta genes with increased risk for oral cancer.
Yapijakis C; Serefoglou Z; Vylliotis A; Nkenke E; Derka S; Vassiliou S; Avgoustidis D; Neukam FW; Patsouris E; Vairaktaris E
Anticancer Res; 2009 Jun; 29(6):2379-86. PubMed ID: 19528505
[TBL] [Abstract][Full Text] [Related]
7. The PON1-108C/T polymorphism, and not the polycystic ovary syndrome, is an important determinant of reduced serum paraoxonase activity in premenopausal women.
San Millán JL; Alvarez-Blasco F; Luque-Ramírez M; Botella-Carretero JI; Escobar-Morreale HF
Hum Reprod; 2006 Dec; 21(12):3157-61. PubMed ID: 16880229
[TBL] [Abstract][Full Text] [Related]
8. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children?
Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T
Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651
[TBL] [Abstract][Full Text] [Related]
9. Cyclooxygenase-2-765G>C functional promoter polymorphism and its association with oral squamous cell carcinoma.
Lakshmi A; Muralidhar S; Kalyan Kumar C; Pavan Kumar A; Kalyana Chakravarthy P; Anjaneyulu V; Kaiser J
J Investig Clin Dent; 2012 Aug; 3(3):182-8. PubMed ID: 22887904
[TBL] [Abstract][Full Text] [Related]
10. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease].
Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666
[TBL] [Abstract][Full Text] [Related]
11. Paraoxonase 1 gene polymorphisms, paraoxonase/arylesterase activities and oxidized low-density lipoprotein levels in patients with migraine.
Yıldırım S; Akar S; Kuyucu M; Yıldırım A; Dane S; Aygül R
Cell Biochem Funct; 2011 Oct; 29(7):549-54. PubMed ID: 21755523
[TBL] [Abstract][Full Text] [Related]
12. Association of matrix metalloproteinase-1 (-1607 1G/2G) polymorphism with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Derka S; Serefoglou Z; Vassiliou S; Nkenke E; Ragos V; Vylliotis A; Spyridonidou S; Tsigris C; Yannopoulos A; Tesseromatis C; Neukam FW; Patsouris E
Anticancer Res; 2007; 27(1A):459-64. PubMed ID: 17352267
[TBL] [Abstract][Full Text] [Related]
13. The interleukin-8 (-251A/T) polymorphism is associated with increased risk for oral squamous cell carcinoma.
Vairaktaris E; Yapijakis C; Serefoglou Z; Derka S; Vassiliou S; Nkenke E; Vylliotis A; Wiltfang J; Avgoustidis D; Critselis E; Neukam FW; Patsouris E
Eur J Surg Oncol; 2007 May; 33(4):504-7. PubMed ID: 17174061
[TBL] [Abstract][Full Text] [Related]
14. Quantitative evaluation of serum fucose in oral squamous cell carcinoma patients.
Parwani RN; Parwani SR
J Cancer Res Ther; 2011; 7(2):143-7. PubMed ID: 21768700
[TBL] [Abstract][Full Text] [Related]
15. Role of L-MYC polymorphism in oral squamous cell carcinoma in Turkey.
Bektas-Kayhan K; Unür M; Yaylim-Eraltan I; Ergen A; Hafiz G; Karadeniz A; Isbir T
Anticancer Res; 2009 Jul; 29(7):2519-24. PubMed ID: 19596922
[TBL] [Abstract][Full Text] [Related]
16. Investigating paraoxonase-1 gene Q192R and L55M polymorphism in patients with renal cell cancer.
Uyar OA; Kara M; Erol D; Ardicoglu A; Yuce H
Genet Mol Res; 2011 Feb; 10(1):133-9. PubMed ID: 21308654
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
18. Tumor necrosis factor-alpha promoter polymorphism is associated with susceptibility to oral squamous cell carcinoma.
Liu CJ; Wong YK; Chang KW; Chang HC; Liu HF; Lee YJ
J Oral Pathol Med; 2005 Nov; 34(10):608-12. PubMed ID: 16202081
[TBL] [Abstract][Full Text] [Related]
19. Investigation of the common paraoxonase 1 variants with paraoxonase activity on bone fragility in Turkish patients.
Toptaş B; Kurt Ö; Aydoğan HY; Yaylim I; Zeybek Ü; Can A; Agachan B; Uyar M; Özyavuz MK; Isbir T
Mol Biol Rep; 2013 Nov; 40(11):6519-24. PubMed ID: 24057271
[TBL] [Abstract][Full Text] [Related]
20. Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.
Gupta N; Binukumar BK; Singh S; Sunkaria A; Kandimalla R; Bhansali A; Gill KD
Gene; 2011 Nov; 487(1):88-95. PubMed ID: 21803130
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
